Merck & Co., Inc.

Filed a patent for "sustained-release formulations for poorly permeable cyclic peptides" on Thu, August 24, 2023

Filed a patent for "rna interference mediated inhibition of prolyl hydroxylase domain 2 (phd2) gene expression using short interfering nucleic acid (sina)" on Thu, February 27, 2025

Filed a patent for "lipolytic activity assay" on Tue, August 15, 2023

Filed a patent for "inhibitors of human respiratory syncytial virus and metapneumovirus" on Thu, August 17, 2023

Filed a patent for "methods for detecting pcr chimeras" on Thu, August 17, 2023

Filed a patent for "monovalent interleukin 12 (il-12) heterodimeric fc proteins" on Fri, August 11, 2023

Filed a patent for "methods for treating myeloproliferative disorders" on Thu, February 6, 2025

Filed a patent for "solid dosage form of a small molecule antiviral and uses thereof" on Thu, July 27, 2023

Filed a patent for "tetrahydroquinazoline derivatives as selective cytotoxic agents" on Fri, July 7, 2023

Filed a patent for "spirocyclic wrn helicase inhibitors" on Tue, July 11, 2023

Filed a patent for "spirocyclic wrn helicase inhibitors" on Tue, August 15, 2023

Filed a patent for "inhibitors of human respiratory syncytial virus and metapneumovirus" on Mon, June 26, 2023

Filed a patent for "processes for preparing soluble guanylate cyclase stimulators" on Mon, June 26, 2023

Filed a patent for "chimeric antigen receptors and use thereof" on Wed, June 14, 2023

Filed a patent for "use of a long-acting oxyntomodulin derivative for treament of fatty liver disease" on Fri, June 23, 2023

Filed a patent for "vaccine for equine herpesvirus" on Fri, February 2, 2024

Filed a patent for "anti-trop2 antibody-drug conjugates comprising pnu-159682 derivatives" on Mon, April 24, 2023

Filed a patent for "delivery devices for anti-hiv compounds" on Fri, April 28, 2023

Filed a patent for "cyclic peptides as pet imaging agents of granzyme b" on Wed, May 3, 2023

Filed a patent for "small molecule inhibitors of kras g12d mutant" on Tue, May 9, 2023

Filed a patent for "methods of improving lung diffusion capacity in a patient with pulmonary arterial hypertension" on Fri, May 12, 2023

Filed a patent for "compounds and formulations useful as vaccine adjuvants" on Thu, May 18, 2023

Filed a patent for "5,6 saturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3" on Fri, June 2, 2023

Filed a patent for "orexin receptor agonists" on Thu, July 27, 2023

Filed a patent for "methods for treating acute myeloid leukemia with anti-ilt3 antibodies" on Wed, January 24, 2024